Our Products in Action
Multiplo Multiplex Tests
MedMira’s Multiplo multiplex tests include combination testing solutions for HIV-1/2, Hepatitis B and C, and Syphilis.
MedMira is dedicated to improving human health by providing the best in rapid diagnostics. Our patented Rapid Vertical Flow Technology™ delivers fast, accurate results for a range of applications—helping care providers and their patients know more, instantly.
MedMira Announces AGM Results and Stock Option Grant
Halifax, Nova Scotia, June 29, 2017 – MedMira Inc. (MedMira) (TSXV: MIR), held its 2018 Annual General Meeting of Shareholders on January 31, 2018 in Halifax, Nova Scotia.
MedMira Reports First Quarter Results
Halifax, Nova Scotia, December 22, 2017 – MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended October 31, 2017.
MedMira Reports 2017 Fourth Quarter and Year End Financial Results
Halifax, Nova Scotia, March 31, 2017 – MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter and year ended July 31, 2017.